AMFPF
Price
$18.00
Change
-$0.09 (-0.50%)
Updated
Oct 21 closing price
Capitalization
4B
Intraday Buy/Sell Signals
NSVGF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
May 20 closing price
Capitalization
3.29M
Intraday Buy/Sell Signals
Interact to see
Advertisement

AMFPF vs NSVGF

Header iconAMFPF vs NSVGF Comparison
Open Charts AMFPF vs NSVGFBanner chart's image
Amplifon S.p.A
Price$18.00
Change-$0.09 (-0.50%)
Volume$1.2K
Capitalization4B
Nass Vy Gateway
Price$0.01
Change-$0.00 (-0.00%)
Volume$34.5K
Capitalization3.29M
AMFPF vs NSVGF Comparison Chart in %
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMFPF vs. NSVGF commentary
Oct 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFPF is a Hold and NSVGF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 26, 2025
Stock price -- (AMFPF: $18.00 vs. NSVGF: $0.01)
Brand notoriety: AMFPF and NSVGF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: AMFPF: 18% vs. NSVGF: 100%
Market capitalization -- AMFPF: $4B vs. NSVGF: $3.29M
AMFPF [@Medical Distributors] is valued at $4B. NSVGF’s [@Medical Distributors] market capitalization is $3.29M. The market cap for tickers in the [@Medical Distributors] industry ranges from $99.72B to $0. The average market capitalization across the [@Medical Distributors] industry is $11.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMFPF’s FA Score shows that 0 FA rating(s) are green whileNSVGF’s FA Score has 0 green FA rating(s).

  • AMFPF’s FA Score: 0 green, 5 red.
  • NSVGF’s FA Score: 0 green, 5 red.
According to our system of comparison, AMFPF is a better buy in the long-term than NSVGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMFPF’s TA Score shows that 6 TA indicator(s) are bullish.

  • AMFPF’s TA Score: 6 bullish, 1 bearish.

Price Growth

AMFPF (@Medical Distributors) experienced а -0.50% price change this week, while NSVGF (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.32%. For the same industry, the average monthly price growth was +3.71%, and the average quarterly price growth was +9.17%.

Industries' Descriptions

@Medical Distributors (+2.32% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMFPF($4B) has a higher market cap than NSVGF($3.29M). NSVGF YTD gains are higher at: 0.000 vs. AMFPF (-30.776).
AMFPFNSVGFAMFPF / NSVGF
Capitalization4B3.29M121,600%
EBITDA549MN/A-
Gain YTD-30.7760.000-
P/E Ratio27.81N/A-
Revenue2.41BN/A-
Total Cash243MN/A-
Total Debt1.83BN/A-
FUNDAMENTALS RATINGS
AMFPF vs NSVGF: Fundamental Ratings
AMFPF
NSVGF
OUTLOOK RATING
1..100
9341
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
64100
PRICE GROWTH RATING
1..100
8276
P/E GROWTH RATING
1..100
81100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMFPF's Valuation (50) in the null industry is in the same range as NSVGF (50). This means that AMFPF’s stock grew similarly to NSVGF’s over the last 12 months.

AMFPF's Profit vs Risk Rating (100) in the null industry is in the same range as NSVGF (100). This means that AMFPF’s stock grew similarly to NSVGF’s over the last 12 months.

AMFPF's SMR Rating (64) in the null industry is somewhat better than the same rating for NSVGF (100). This means that AMFPF’s stock grew somewhat faster than NSVGF’s over the last 12 months.

NSVGF's Price Growth Rating (76) in the null industry is in the same range as AMFPF (82). This means that NSVGF’s stock grew similarly to AMFPF’s over the last 12 months.

AMFPF's P/E Growth Rating (81) in the null industry is in the same range as NSVGF (100). This means that AMFPF’s stock grew similarly to NSVGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMFPFNSVGF
RSI
ODDS (%)
Bullish Trend 2 days ago
22%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
27%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
14%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
31%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
22%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
23%
Bullish Trend 2 days ago
57%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
50%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLNCX51.190.17
+0.33%
Russell Inv International Devd Mkts C
GSPQX18.71N/A
N/A
Goldman Sachs US Eq Div and Premium C
VTWAX49.35N/A
N/A
Vanguard Total World Stock Index Admiral
TAGDX16.65N/A
N/A
Transamerica Large Growth R6
SJVAX30.77N/A
N/A
Steward Large Cap Value A

AMFPF and

Correlation & Price change

A.I.dvisor tells us that AMFPF and ZYXI have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMFPF and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMFPF
1D Price
Change %
AMFPF100%
N/A
ZYXI - AMFPF
10%
Poorly correlated
+2.94%
COSM - AMFPF
2%
Poorly correlated
-0.97%
NSVGF - AMFPF
1%
Poorly correlated
N/A
SHPMY - AMFPF
0%
Poorly correlated
N/A
MAHLY - AMFPF
0%
Poorly correlated
N/A
More

NSVGF and

Correlation & Price change

A.I.dvisor tells us that NSVGF and SHPMY have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSVGF and SHPMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSVGF
1D Price
Change %
NSVGF100%
N/A
SHPMY - NSVGF
14%
Poorly correlated
N/A
ZYXI - NSVGF
8%
Poorly correlated
+2.94%
PDRX - NSVGF
8%
Poorly correlated
N/A
SHTDF - NSVGF
4%
Poorly correlated
N/A
AMFPF - NSVGF
1%
Poorly correlated
N/A
More